Nabriva Therapeutics Plc

-0.06 (-3.93%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)63.61M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.3 Million
Adjusted EPS-$0.33
See more estimates
10-Day MA$1.40
50-Day MA$1.49
200-Day MA$3.12
See more pivots

Nabriva Therapeutics Plc Stock, NASDAQ:NBRV

25-28 North Wall Quay, IFSC, Dublin, Dublin 1
Phone: +353.1.649.2000
Number of Employees: 72


Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland.